Literature DB >> 17451191

Prenatal detection of congenital bilateral cataract leading to the diagnosis of Nance-Horan syndrome in the extended family.

Adi Reches1, Yuval Yaron, Kathryn Burdon, Ornit Crystal-Shalit, Dvora Kidron, Mira Malcov, Ron Tepper.   

Abstract

OBJECTIVES: To describe a family in which it was possible to perform prenatal diagnosis of Nance-Horan Syndrome (NHS).
METHODS: The fetus was evaluated by 2nd trimester ultrasound. The family underwent genetic counseling and ophthalmologic evaluation. The NHS gene was sequenced.
RESULTS: Ultrasound demonstrated fetal bilateral congenital cataract. Clinical evaluation revealed other family members with cataract, leading to the diagnosis of NHS in the family. Sequencing confirmed a frameshift mutation (3908del11bp) in the NHS gene.
CONCLUSION: Evaluation of prenatally diagnosed congenital cataract should include a multidisciplinary approach, combining experience and input from sonographer, clinical geneticist, ophthalmologist, and molecular geneticist.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17451191     DOI: 10.1002/pd.1734

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  12 in total

1.  A novel syndrome of paediatric cataract, dysmorphism, ectodermal features, and developmental delay in Australian Aboriginal family maps to 1p35.3-p36.32.

Authors:  Kathryn Hattersley; Kate J Laurie; Jan E Liebelt; Jozef Gecz; Shane R Durkin; Jamie E Craig; Kathryn P Burdon
Journal:  BMC Med Genet       Date:  2010-11-19       Impact factor: 2.103

2.  MRI of the fetal eyes: morphologic and biometric assessment for abnormal development with ultrasonographic and clinicopathologic correlation.

Authors:  Ashley J Robinson; Susan Blaser; Ants Toi; David Chitayat; Sophie Pantazi; Sarah Keating; Sandra Viero; Greg Ryan
Journal:  Pediatr Radiol       Date:  2008-07-17

3.  Epidemiology and molecular genetics of congenital cataracts.

Authors:  Jun Yi; Jun Yun; Zhi-Kui Li; Chang-Tai Xu; Bo-Rong Pan
Journal:  Int J Ophthalmol       Date:  2011-08-18       Impact factor: 1.779

4.  The first missense mutation of NHS gene in a Tunisian family with clinical features of NHS syndrome including cardiac anomaly.

Authors:  Manèl Chograni; Imen Rejeb; Lamia Ben Jemaa; Myriam Châabouni; Habiba Chaabouni Bouhamed
Journal:  Eur J Hum Genet       Date:  2011-05-11       Impact factor: 4.246

5.  Ophthalmic pathology of Nance-Horan syndrome: case report and review of the literature.

Authors:  Xiaoyan Ding; Mrinali Patel; Alexandra A Herzlich; Pamela C Sieving; Chi-Chao Chan
Journal:  Ophthalmic Genet       Date:  2009-09       Impact factor: 1.803

Review 6.  Congenital cataracts and their molecular genetics.

Authors:  J Fielding Hejtmancik
Journal:  Semin Cell Dev Biol       Date:  2007-10-10       Impact factor: 7.727

7.  A novel small deletion in the NHS gene associated with Nance-Horan syndrome.

Authors:  Huajin Li; Lizhu Yang; Zixi Sun; Zhisheng Yuan; Shijing Wu; Ruifang Sui
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

8.  Nance-Horan Syndrome: A Rare Case Report.

Authors:  Shambhu Sharma; Pankaj Datta; Janak Raj Sabharwal; Sonia Datta
Journal:  Contemp Clin Dent       Date:  2017 Jul-Sep

9.  X-linked cataract and Nance-Horan syndrome are allelic disorders.

Authors:  Margherita Coccia; Simon P Brooks; Tom R Webb; Katja Christodoulou; Izabella O Wozniak; Victoria Murday; Martha Balicki; Harris A Yee; Teresia Wangensteen; Ruth Riise; Anand K Saggar; Soo-Mi Park; Naheed Kanuga; Peter J Francis; Eamonn R Maher; Anthony T Moore; Isabelle M Russell-Eggitt; Alison J Hardcastle
Journal:  Hum Mol Genet       Date:  2009-05-04       Impact factor: 6.150

10.  Novel causative mutations in patients with Nance-Horan syndrome and altered localization of the mutant NHS-A protein isoform.

Authors:  Shiwani Sharma; Kathryn P Burdon; Alpana Dave; Robyn V Jamieson; Yuval Yaron; Frank Billson; Lionel Van Maldergem; Birgit Lorenz; Jozef Gécz; Jamie E Craig
Journal:  Mol Vis       Date:  2008-10-20       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.